Hana Lim

Dr. Hana Lim


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HLHana Lim
Hana Lim
KHKatherine A. Hajjar
Katherine A. Hajjar
As a cell surface tissue plasminogen activator (tPA)-plasminogen receptor, the annexin A2 (A2) complex facilitates plasmin generation on the endothelial cell surface, and is an established regulator of hemostasis. Whereas A2 is overexpressed in hemorrhagic disease such as acute promyelocytic leukemia, its underexpression or impairment may result in thrombosis, as in antiphospholipid syndrome, venous thromboembolism, or atherosclerosis. Within immune response cells, A2 orchestrates membrane repair, vesicle fusion, and cytoskeletal organization, thus playing a critical role in inflammatory response and tissue injury. Dysregulation of A2 is evident in multiple human disorders, and may contribute to the pathogenesis of various inflammatory disorders. The fibrinolytic system, moreover, is central to wound healing through its ability to remodel the provisional matrix and promote angiogenesis. A2 dysfunction may also promote tissue fibrogenesis and end-organ fibrosis.

1 September 2023 in Stroke
Verified
Journal Article
Closed access
NPNeal S. Parikh
Neal S. Parikh
EBElora Basu
Elora Basu
MHMu Ji Hwang
Mu Ji Hwang
RRRussel Rosenblatt
Russel Rosenblatt
LVLisa B. VanWagner
Lisa B. VanWagner
HKHooman Kamel
Hooman Kamel
Chronic liver disease (CLD) is a highly prevalent condition. There is burgeoning recognition that there are many people with subclinical liver disease that may nonetheless be clinically significant. CLD has a variety of systemic aberrations relevant to stroke, including thrombocytopenia, coagulopathy, elevated liver enzymes, and altered drug metabolism. There is a growing body of literature on the intersection of CLD and stroke. Despite this, there have been few efforts to synthesize these data, and stroke guidelines provide scant guidance on this topic. To fill this gap, this multidisciplinary review provides a contemporary overview of CLD for the vascular neurologist while appraising data regarding the impact of CLD on stroke risk, mechanisms, and outcomes. Finally, the review addresses acute and chronic treatment considerations for patients with stroke—ischemic and hemorrhagic—and CLD.

19 March 2026 in Blood Vessels, Thrombosis & Hemostasis
Verified
Journal Article
Open access
HLHana Lim
Hana Lim
MBMichael Bender
Michael Bender
HCHuigen Chen
Huigen Chen
FWFrances M. West
Frances M. West
JLJulio Lanfranco
Julio Lanfranco
KHKatherine A. Hajjar
Katherine A. Hajjar
• Sepsis-triggered proteolysis of A2 reduces cell surface fibrinolytic activity. • A2 proteolysis is associated with microvasculopathic organ dysfunction in humans.

11 September 2024 in eJHaem
Verified
Journal Article
Open access
IBIvo Sah Bandar
Ivo Sah Bandar
GMGustavo H. B. Maegawa
Gustavo H. B. Maegawa
DBDanielle Brandman
Danielle Brandman
JRJacob H. Rand
Jacob H. Rand
HLHana Lim
Hana Lim
JGJulia T. Geyer
Julia T. Geyer